This cohort study of patients with breast cancer investigates whether Ki-67 expression correlates with the 21-gene recurrence score (RS) and whether high Ki-67 level in patients with a low RS is associated with recurrence and secondary endocrine resistance. This evidence concerns the gene MKI67 and breast cancer.